Biofreedom Prospective Multicenter Observational Registry

TerminatedOBSERVATIONAL
Enrollment

194

Participants

Timeline

Start Date

July 5, 2018

Primary Completion Date

June 30, 2020

Study Completion Date

November 10, 2020

Conditions
Coronary Artery Disease AggravatedMyocardial IschemiaMyocardial Infarction
Interventions
DEVICE

Biofreedom drug-coated stent

BioFreedom (Biosensors International Technologies, Singapore) is the only polymer- and carrier-free drug coated stent with Biolimus A9 in a selectively micro-structured abluminal surface. It is a stainless steel bare metal surface with 120 micron thick corrugated ring strut.

Trial Locations (16)

13495

CHA Bundang Medical Center, Seongnam-si

16499

Ajou University Hospital, Suwon

21565

Gachon University Gil Medical Center, Incheon

26426

Wonju Severance Christian Hospital, Wŏnju

31116

Dankook University Hospital, Cheonan

42415

Yeungnam University Medical Center, Daegu

42472

Daegu Catholic University Medical Center, Daegu

50612

Pusan National University Yangsan Hospital, Pusan

200-722

Kangwon National University School of Medicine, Chuncheon

420-767

Soonchunhyang University Bucheon Hospital, Bucheon-si

01830

Eulji General Hospital, Seoul

05278

KyungHee University at Gangdong, Seoul

06273

Gangnam Severance Hospital, Seoul

06973

Chung-Ang University Hospital, Seoul

07061

Seoul National University Boramae Medical Center, Seoul

134-791

Veterans Health Service Medical Center, Seoul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Cordis Corporation

INDUSTRY

lead

Wonju Severance Christian Hospital

OTHER